Genova files patent for new prostate cancer treatment

GENova Biotherapeutics, Inc., is pleased to announce that it has filed a patent for a novel peptide that disrupts the advance of prostate cancer and thus has blockbuster potential as a new anti-cancer drug.

The details can be read here.